Total Payments
$23,067
2024 Payments
$1,647
Companies
73
Transactions
640
Medicare Patients
5,369
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$11,970 (51.9%)
Consulting$10,395 (45.1%)
Education$645.95 (2.8%)
Travel$56.00 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,970 | 619 | 51.9% |
| Consulting Fee | $10,395 | 5 | 45.1% |
| Education | $645.95 | 14 | 2.8% |
| Travel and Lodging | $56.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,658 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,825 | 55 | $0 (2024) |
| Heron Therapeutics, Inc. | $2,722 | 3 | $0 (2017) |
| Puma Biotechnology, Inc. | $1,198 | 7 | $0 (2019) |
| Merck Sharp & Dohme LLC | $1,127 | 63 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $827.38 | 54 | $0 (2024) |
| Genentech USA, Inc. | $737.30 | 39 | $0 (2024) |
| PFIZER INC. | $651.68 | 47 | $0 (2024) |
| Janssen Biotech, Inc. | $616.35 | 31 | $0 (2024) |
| Celgene Corporation | $498.73 | 27 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,647 | 71 | Janssen Biotech, Inc. ($139.69) |
| 2023 | $1,279 | 58 | E.R. Squibb & Sons, L.L.C. ($155.51) |
| 2022 | $1,305 | 66 | Novartis Pharmaceuticals Corporation ($171.55) |
| 2021 | $1,109 | 57 | Novartis Pharmaceuticals Corporation ($146.95) |
| 2020 | $519.97 | 27 | Genentech USA, Inc. ($61.62) |
| 2019 | $7,921 | 130 | Novartis Pharmaceuticals Corporation ($3,033) |
| 2018 | $2,808 | 102 | Puma Biotechnology, Inc. ($1,172) |
| 2017 | $6,478 | 129 | Heron Therapeutics, Inc. ($2,722) |
All Payment Transactions
640 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.70 | General |
| 12/17/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/10/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Genetically Defined Disease | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.54 | General |
| 11/26/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $38.97 | General |
| Category: Oncology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: Oncology | ||||||
| 11/15/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Amneal Pharmaceuticals LLC | AVASTIN (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 09/29/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Oncology | ||||||
| 09/10/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,192 | 13,890 | $1.6M | $403,523 |
| 2022 | 31 | 1,462 | 18,298 | $2.4M | $575,870 |
| 2021 | 25 | 1,320 | 41,981 | $1.8M | $438,085 |
| 2020 | 25 | 1,395 | 19,128 | $1.2M | $243,624 |
Total Patients
5,369
Total Services
93,297
Medicare Billing
$1.7M
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 16 | 5,400 | $796,200 | $234,688 | 29.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 271 | 710 | $191,700 | $45,958 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 422 | $168,800 | $40,486 | 24.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 242 | 285 | $145,350 | $30,162 | 20.8% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 11 | 12 | $49,440 | $15,623 | 31.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 65 | 111 | $76,146 | $11,950 | 15.7% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 12 | 13 | $8,294 | $5,215 | 62.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $15,500 | $3,019 | 19.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 38 | 102 | $15,504 | $2,378 | 15.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $12,000 | $2,297 | 19.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 32 | $6,560 | $1,934 | 29.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 29 | $8,816 | $1,548 | 17.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 44 | 116 | $12,180 | $1,487 | 12.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 20 | 56 | $8,736 | $1,314 | 15.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 13 | 24 | $8,016 | $1,234 | 15.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 103 | $9,579 | $1,167 | 12.2% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2023 | 14 | 25 | $7,025 | $1,078 | 15.3% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2023 | 21 | 5,250 | $34,500 | $645.79 | 1.9% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 15 | 17 | $4,233 | $456.85 | 10.8% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 16 | 17 | $1,530 | $379.50 | 24.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 25 | 410 | $50,020 | $353.60 | 0.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 34 | 640 | $1,720 | $59.63 | 3.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 31 | $589.00 | $35.58 | 6.0% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 13 | 15 | $285.00 | $30.29 | 10.6% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 13 | 29 | $203.00 | $23.99 | 11.8% |
About Dr. Ronald Myint, M.D
Dr. Ronald Myint, M.D is a Internal Medicine healthcare provider based in Oak Lawn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1003076795.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Myint, M.D has received a total of $23,067 in payments from pharmaceutical and medical device companies, with $1,647 received in 2024. These payments were reported across 640 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($11,970).
As a Medicare-enrolled provider, Myint has provided services to 5,369 Medicare beneficiaries, totaling 93,297 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology
- Location Oak Lawn, IL
- Active Since 06/16/2008
- Last Updated 03/25/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003076795
Products in Payments
- MEKINIST (Drug) $3,117
- CALQUENCE (Drug) $2,879
- SUSTOL (Drug) $2,722
- Nerlynx (Drug) $1,198
- KEYTRUDA (Biological) $1,033
- OPDIVO (Biological) $582.18
- XARELTO (Drug) $278.88
- ZEJULA (Drug) $259.13
- Lenvima (Drug) $258.71
- Imbruvica (Drug) $243.80
- TECENTRIQ (Biological) $233.77
- KISQALI (Drug) $205.59
- CYRAMZA (Drug) $193.18
- IMBRUVICA (Drug) $174.64
- ELIQUIS (Drug) $171.14
- JAKAFI (Drug) $170.25
- Avastin (Biological) $165.88
- DARZALEX (Biological) $164.76
- Revlimid (Drug) $154.65
- LYNPARZA (Drug) $145.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oak Lawn
William Cruikshank, M.d, M.D
Internal Medicine — Payments: $430,646
Internal Medicine $430,646
Dr. Sunil Pauwaa, M.d, M.D
Internal Medicine — Payments: $132,610
Internal Medicine $132,610
William Janes, M.d, M.D
Internal Medicine — Payments: $37,745
Internal Medicine $37,745
Win Myint, Md, MD
Internal Medicine — Payments: $28,040
Internal Medicine $28,040
Ambar Andrade, M.d., Facc, M.D., FACC
Internal Medicine — Payments: $23,629
Internal Medicine $23,629
Dr. Jeffrey Neiger, Md, MD
Internal Medicine — Payments: $22,232
Internal Medicine $22,232